Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease.
Saved in:
| Title: | Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease. |
|---|---|
| Authors: | Pfeifer H; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany., Bethge W; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University of Tuebingen Medical Center, Tuebingen, Germany., Schönland S; Department of Hematology/Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany., Heberling L; Department of Internal Medicine I, Haematology and Oncology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany., Ruhnke L; Department of Internal Medicine I, Haematology and Oncology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany., Stadler M; Department of Hematology, Hemostasis, Oncology, and Cellular Therapy, Hannover Medical School, Hannover, Germany., Beelen D; Department of Haematology and Stem Cell Transplantation, University of Duisburg-Essen, University Medicine Essen, Essen, Germany., Vučinić V; Department of Hematology, Hemostaseology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany., Burmeister T; Department of Hematology, Oncology and Tumor Immunology, Campus Virchow Clinic, Campus Charité-Mitte and Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany., Stelljes M; Department of Medicine A/Hematology and Oncology, University of Muenster, Muenster, Germany., Faul C; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University of Tuebingen Medical Center, Tuebingen, Germany., Kiani A; Department of Medicine IV, Klinikum Bayreuth GmbH, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Wendelin K; Oncology, Hematology and Bone Marrow Transplantation Unit, Paracelsus Medizinische Privatuniversitat - Nurnberg, Nürnberg, Germany., Schwerdtfeger R; Helios Klinikum Buch, Berlin, Germany., Lange E; Clinic for Hematology, Oncology and Palliative Care and Stem Cell Transplantation, Alexianer Hospital Hochsauerland, Meschede, Germany., Kubuschock B; Department of Internal Medicine II, Augsburg University Medical Center and Bavarian Cancer Research Center (BZKF), Partner Cite Augsburg, Augsburg, Germany., Horst HA; University Hospital Schleswig Holstein, Kiel, Germany., Gramatzki M; Division of Stem Cell Transplantation and Immunotherapy, University of Kiel, Kiel, Germany., Serve H; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany.; Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Frankfurt, Germany.; Frankfurt Cancer Institute (FCI, Frankfurt), Frankfurt, Germany., Hoelzer D; Onkologikum Frankfurt, Frankfurt, Germany., Gökbuget N; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany., Ottmann OG; Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK., Lang F; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany. |
| Corporate Authors: | GMALL Study Group |
| Source: | Leukemia & lymphoma [Leuk Lymphoma] 2026 Aug 02, pp. 1-9. Date of Electronic Publication: 2026 Aug 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42543021 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pfeifer+H%22">Pfeifer H</searchLink>; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Bethge+W%22">Bethge W</searchLink>; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University of Tuebingen Medical Center, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Schönland+S%22">Schönland S</searchLink>; Department of Hematology/Oncology and Rheumatology, University of Heidelberg, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Heberling+L%22">Heberling L</searchLink>; Department of Internal Medicine I, Haematology and Oncology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Ruhnke+L%22">Ruhnke L</searchLink>; Department of Internal Medicine I, Haematology and Oncology, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.<br /><searchLink fieldCode="AU" term="%22Stadler+M%22">Stadler M</searchLink>; Department of Hematology, Hemostasis, Oncology, and Cellular Therapy, Hannover Medical School, Hannover, Germany.<br /><searchLink fieldCode="AU" term="%22Beelen+D%22">Beelen D</searchLink>; Department of Haematology and Stem Cell Transplantation, University of Duisburg-Essen, University Medicine Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Vučinić+V%22">Vučinić V</searchLink>; Department of Hematology, Hemostaseology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.<br /><searchLink fieldCode="AU" term="%22Burmeister+T%22">Burmeister T</searchLink>; Department of Hematology, Oncology and Tumor Immunology, Campus Virchow Clinic, Campus Charité-Mitte and Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Stelljes+M%22">Stelljes M</searchLink>; Department of Medicine A/Hematology and Oncology, University of Muenster, Muenster, Germany.<br /><searchLink fieldCode="AU" term="%22Faul+C%22">Faul C</searchLink>; Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University of Tuebingen Medical Center, Tuebingen, Germany.<br /><searchLink fieldCode="AU" term="%22Kiani+A%22">Kiani A</searchLink>; Department of Medicine IV, Klinikum Bayreuth GmbH, Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany.<br /><searchLink fieldCode="AU" term="%22Wendelin+K%22">Wendelin K</searchLink>; Oncology, Hematology and Bone Marrow Transplantation Unit, Paracelsus Medizinische Privatuniversitat - Nurnberg, Nürnberg, Germany.<br /><searchLink fieldCode="AU" term="%22Schwerdtfeger+R%22">Schwerdtfeger R</searchLink>; Helios Klinikum Buch, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Lange+E%22">Lange E</searchLink>; Clinic for Hematology, Oncology and Palliative Care and Stem Cell Transplantation, Alexianer Hospital Hochsauerland, Meschede, Germany.<br /><searchLink fieldCode="AU" term="%22Kubuschock+B%22">Kubuschock B</searchLink>; Department of Internal Medicine II, Augsburg University Medical Center and Bavarian Cancer Research Center (BZKF), Partner Cite Augsburg, Augsburg, Germany.<br /><searchLink fieldCode="AU" term="%22Horst+HA%22">Horst HA</searchLink>; University Hospital Schleswig Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Gramatzki+M%22">Gramatzki M</searchLink>; Division of Stem Cell Transplantation and Immunotherapy, University of Kiel, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Serve+H%22">Serve H</searchLink>; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany.; Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Frankfurt, Germany.; Frankfurt Cancer Institute (FCI, Frankfurt), Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Hoelzer+D%22">Hoelzer D</searchLink>; Onkologikum Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Gökbuget+N%22">Gökbuget N</searchLink>; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany.<br /><searchLink fieldCode="AU" term="%22Ottmann+OG%22">Ottmann OG</searchLink>; Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, UK.<br /><searchLink fieldCode="AU" term="%22Lang+F%22">Lang F</searchLink>; Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt, Germany. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22GMALL+Study+Group%22">GMALL Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229007422%22">Leukemia & lymphoma</searchLink> [Leuk Lymphoma] 2026 Aug 02, pp. 1-9. <i>Date of Electronic Publication: </i>2026 Aug 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Taylor+%26+Francis%22">Taylor & Francis </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9007422 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1029-2403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210268022%22">10268022 </searchLink><i>NLM ISO Abbreviation: </i>Leuk Lymphoma <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42543021 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1080/10428194.2026.2707442 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1 Titles: – TitleFull: Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pfeifer H – PersonEntity: Name: NameFull: Bethge W – PersonEntity: Name: NameFull: Schönland S – PersonEntity: Name: NameFull: Heberling L – PersonEntity: Name: NameFull: Ruhnke L – PersonEntity: Name: NameFull: Stadler M – PersonEntity: Name: NameFull: Beelen D – PersonEntity: Name: NameFull: Vučinić V – PersonEntity: Name: NameFull: Burmeister T – PersonEntity: Name: NameFull: Stelljes M – PersonEntity: Name: NameFull: Faul C – PersonEntity: Name: NameFull: Kiani A – PersonEntity: Name: NameFull: Wendelin K – PersonEntity: Name: NameFull: Schwerdtfeger R – PersonEntity: Name: NameFull: Lange E – PersonEntity: Name: NameFull: Kubuschock B – PersonEntity: Name: NameFull: Horst HA – PersonEntity: Name: NameFull: Gramatzki M – PersonEntity: Name: NameFull: Serve H – PersonEntity: Name: NameFull: Hoelzer D – PersonEntity: Name: NameFull: Gökbuget N – PersonEntity: Name: NameFull: Ottmann OG – PersonEntity: Name: NameFull: Lang F IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 08 Text: 2026 Aug 02 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1029-2403 Titles: – TitleFull: Leukemia & lymphoma Type: main |
| ResultId | 1 |
